Spots Global Cancer Trial Database for turbt
Every month we try and update this database with for turbt cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) | NCT01469221 | Bladder Cancer | Apaziquone Placebo | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Study of Intravesical Apaziquone as a Surgical Adjuvant in Participant Undergoing Transurethral Resection Bladder Tumor (TURBT) | NCT02563561 | Bladder Cancer | Apaziquone Placebo | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC) | NCT01469221 | Bladder Cancer | Apaziquone Placebo | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| En Bloc Bladder Tumor Resection: Prospective Randomized Study | NCT04712201 | Urothelial Carc... Bladder Cancer | En bloc transur... Conventional TU... | 18 Years - | Fundacio Puigvert | |
| Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT | NCT04839029 | Bladder Cancer Bladder Neoplas... | Bipolar En bloc... Monopolar En bl... | 18 Years - | Benha University | |
| Safety and Efficacy of Bipolar vs Monopolar Transurethral Resection of Bladder Tumor-A Randomized Controlled Trial | NCT04234165 | Obturator Jerk ... | TURBT | - | Tribhuvan University, Nepal | |
| En Bloc Bladder Tumor Resection: Prospective Randomized Study | NCT04712201 | Urothelial Carc... Bladder Cancer | En bloc transur... Conventional TU... | 18 Years - | Fundacio Puigvert | |
| Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer | NCT01410565 | Bladder Cancer | Apaziquone Placebo | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer | NCT06335667 | Urothelial Blad... Muscle-Invasive... | mpMRI + Diagnos... | 18 Years - | University of California, Irvine | |
| mpMRI Compared to Diagnostic TURBT in Patients With Suspected Muscle-Invasive Bladder Cancer | NCT06335667 | Urothelial Blad... Muscle-Invasive... | mpMRI + Diagnos... | 18 Years - | University of California, Irvine | |
| Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) | NCT01475266 | Bladder Cancer | EO9 (Apaziquone... Placebo | 20 Years - | Nippon Kayaku Co., Ltd. | |
| Transurethral En Bloc Versus Standard Resection of Bladder Tumour | NCT02993211 | Bladder Cancer | Bipolar transur... Bipolar transur... | 18 Years - | Chinese University of Hong Kong | |
| Efficacy and Safety of Multi-Instillations of Apaziquone in Patients With Non-Muscle Invasive Bladder Cancer | NCT01410565 | Bladder Cancer | Apaziquone Placebo | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure | NCT00615043 | Bladder Disease | Bladder biopsy | 18 Years - 90 Years | Tengion | |
| Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) | NCT00598806 | Bladder Cancer | Apaziquone Placebo TURBT | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Phase 3 Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer | NCT04688931 | Bladder Cancer Urothelial Carc... Urothelial Carc... | UGN-102 TURBT | 18 Years - | UroGen Pharma Ltd. | |
| Transurethral En Bloc Versus Standard Resection of Bladder Tumour | NCT02993211 | Bladder Cancer | Bipolar transur... Bipolar transur... | 18 Years - | Chinese University of Hong Kong | |
| Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | NCT01310803 | Carcinoma in Si... Transitional Ce... Non-muscle Inva... | VALSTAR - Maint... No Maintenance ... | 18 Years - | Endo Pharmaceuticals | |
| Blue Light Cystoscopy With Cysview® Registry | NCT02660645 | Bladder Cancer | Hexaminolevulin... Karl Storz D-Li... | 18 Years - | Photocure | |
| Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612) | NCT00598806 | Bladder Cancer | Apaziquone Placebo TURBT | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| Trial of Intravesical Measles Virotherapy in Patients With Bladder Cancer Who Are Undergoing Radical Cystectomy | NCT03171493 | Urothelial Carc... | MV-NIS | 18 Years - | Vyriad, Inc. | |
| Multi Center Study to Obtain Bladder Tissue Specimens From Patients Undergoing Transurethral Resection Biopsy Procedure | NCT00615043 | Bladder Disease | Bladder biopsy | 18 Years - 90 Years | Tengion | |
| Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) | NCT03258593 | Urinary Bladder... | Durvalumab Vicineum Acetaminophen Antihistamine Bladder Biopsy TURBT Cystoscopy Urine cytology Electrocardiogr... CT MRI | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Virtual Histology of the Bladder Wall for Bladder Cancer Staging | NCT04369560 | Urinary Bladder... | Magnetic Resona... Gadobutrol intr... Ferumoxytol int... | 18 Years - 90 Years | University of Pittsburgh | |
| Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT | NCT04839029 | Bladder Cancer Bladder Neoplas... | Bipolar En bloc... Monopolar En bl... | 18 Years - | Benha University | |
| Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG) | NCT03258593 | Urinary Bladder... | Durvalumab Vicineum Acetaminophen Antihistamine Bladder Biopsy TURBT Cystoscopy Urine cytology Electrocardiogr... CT MRI | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder | NCT04576286 | Urinary Bladder... | Holmium versus ... | 18 Years - | Ain Shams University | |
| Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) | NCT01475266 | Bladder Cancer | EO9 (Apaziquone... Placebo | 20 Years - | Nippon Kayaku Co., Ltd. | |
| CTC Quantification During TURBT and PKVBT of Transitional Cell Carcinoma in Purging Fluid and Blood | NCT04811846 | Urinary Bladder... Transitional Ce... Urogenital Neop... Circulating Tum... Neoplasms | Bipolar transur... Bipolar transur... | 18 Years - | University Teaching Hospital Hall in Tirol | |
| Personalized Urine Biomarker for Patients With Bladder Cancer | NCT05467267 | Bladder Neoplas... | TURBT | 18 Years - | Ziv Hospital | |
| Validity of Computed Tomography Versus Magnetic Resonance Imaging in Predicting Muscular Invasion of Bladder Cancer | NCT06046469 | Bladder Cancer | CT with contras... MRI pelvis TURBT | - | Menoufia University | |
| A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT | NCT02010203 | Bladder Cancer | HS-410 Placebo BCG | 18 Years - | Heat Biologics | |
| En Bloc Bladder Tumor Resection: Prospective Randomized Study | NCT04712201 | Urothelial Carc... Bladder Cancer | En bloc transur... Conventional TU... | 18 Years - | Fundacio Puigvert | |
| A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer | NCT05483868 | Non-muscle-inva... Muscle-Invasive... | AU-011 AU-011 in Combi... AU-011 in Combi... | 18 Years - | Aura Biosciences | |
| Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm | NCT05779631 | Bladder Cancer | mpMRI plus a sa... TURBT | 18 Years - | Radboud University Medical Center | |
| HIVEC in Patients With Non-Muscle-Invasive Bladder Cancer | NCT06327932 | Non-Muscle-Inva... | TURBT HIVEC Intravesical Ch... Gemcitabine | 18 Years - 80 Years | Affiliated Cancer Hospital & Institute of Guangzhou Medical University | |
| The Performance of Cancer Risk Genes in the Necessity of Secondary TURBT | NCT05112523 | Bladder Cancer | 18 Years - | The First Affiliated Hospital with Nanjing Medical University | ||
| Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) | NCT00461591 | Bladder Cancer | Apaziquone Placebo TURBT | 18 Years - | Spectrum Pharmaceuticals, Inc | |
| A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT | NCT02010203 | Bladder Cancer | HS-410 Placebo BCG | 18 Years - | Heat Biologics | |
| Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder | NCT01310803 | Carcinoma in Si... Transitional Ce... Non-muscle Inva... | VALSTAR - Maint... No Maintenance ... | 18 Years - | Endo Pharmaceuticals | |
| Holmium Versus Bipolar en Bloc Transurethral Resection of Urothelium Tumor of the Urinary Bladder | NCT04576286 | Urinary Bladder... | Holmium versus ... | 18 Years - | Ain Shams University | |
| Personalized Urine Biomarker for Patients With Bladder Cancer | NCT05467267 | Bladder Neoplas... | TURBT | 18 Years - | Ziv Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
